Fortive Corp Goodwill & Intangibles Disclosure
| Intelligent Operating Solutions | Advanced Healthcare Solutions | Total | |||||||||||||||
| Balance, December 31, 2023 | $ | 4,148.9 | $ | 3,116.3 | $ | 7,265.2 | |||||||||||
| Measurement period adjustments for prior year acquisitions | 0.6 | — | 0.6 | ||||||||||||||
| Foreign currency translation and other | (27.8) | (22.0) | (49.8) | ||||||||||||||
| Balance, December 31, 2024 | 4,121.7 | 3,094.3 | 7,216.0 | ||||||||||||||
Attributable to current year acquisitions (a) | 15.1 | 0.8 | 15.9 | ||||||||||||||
| Foreign currency translation and other | 45.9 | 20.5 | 66.4 | ||||||||||||||
| Balance, December 31, 2025 | $ | 4,182.7 | $ | 3,115.6 | $ | 7,298.3 | |||||||||||
(a) Refer to Note 1 for further detail on the current year acquisitions. | |||||||||||||||||
| 2025 | 2024 | ||||||||||||||||||||||
Gross Carrying Amount (a) | Accumulated Amortization (a) | Gross Carrying Amount | Accumulated Amortization | ||||||||||||||||||||
| Finite-lived intangibles: | |||||||||||||||||||||||
| Patents and technology | $ | 917.6 | $ | (671.1) | $ | 916.9 | $ | (573.7) | |||||||||||||||
| Customer relationships and other intangibles | 3,195.7 | (1,711.2) | 3,183.6 | (1,459.5) | |||||||||||||||||||
| Trademarks and trade names | 186.2 | (38.7) | 121.4 | (29.1) | |||||||||||||||||||
| Total finite-lived intangibles | 4,299.5 | (2,421.0) | 4,221.9 | (2,062.3) | |||||||||||||||||||
| Indefinite-lived intangibles: | |||||||||||||||||||||||
| Trademarks and trade names | 309.9 | — | 370.9 | — | |||||||||||||||||||
| Total intangibles | $ | 4,609.4 | $ | (2,421.0) | $ | 4,592.8 | $ | (2,062.3) | |||||||||||||||
(a) During the year ended December 31, 2025, certain trademarks and trade names were reclassified from indefinite-lived intangible assets to finite-lived intangibles. We performed an impairment test at the time of the reclassification and determined that no impairment had occurred. | |||||||||||||||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 25, 2026 | Showing above |
| 2024 | Feb 25, 2025 | |
| 2023 | Feb 27, 2024 | |
| 2022 | Feb 28, 2023 | |
| 2021 | Mar 1, 2022 | |
| 2020 | Feb 26, 2021 | |
| 2019 | Feb 27, 2020 | |
| 2018 | Feb 28, 2019 | |
| 2017 | Feb 28, 2018 | |
| 2016 | Feb 28, 2017 | |
About Goodwill & Intangibles Disclosures
Goodwill and intangible asset disclosures reveal the premium paid in acquisitions and how management assesses whether that premium retains its value. Since goodwill is no longer amortized under US GAAP, the annual impairment test is the only mechanism that adjusts carrying values downward — making the assumptions behind that test critically important for investors.
Key signals: a history of goodwill impairments suggests management consistently overpays for acquisitions. Watch the gap between reporting unit fair value and carrying amount — when fair value exceeds carrying amount by less than 10-20%, a small decline in business performance could trigger a write-down. For finite-lived intangibles, examine useful life assumptions across customer relationships, technology, and trade names; aggressive estimates inflate near-term earnings. Compare total intangibles-to-total-assets ratios against peers to assess acquisition dependency. Rising goodwill as a percentage of equity can signal balance sheet fragility.